Jump Financial
HELP

Jump Financial’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Jump Financial’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Buy
19,453
+1,453
+8% +$7.27K ﹤0.01% 1895
2026
Q1 		$86.4K Buy
+18,000
New +$116K ﹤0.01% 1759
2025
Q4 		– Sell
-55,761
Closed -$328K – 2010
2025
Q3 		$328K Buy
+55,761
New +$395K ﹤0.01% 1454
2024
Q2 		– Sell
-493
Closed -$7.67K – 1889
2024
Q1 		$7.67K Buy
493
+227
+85% +$3.28K ﹤0.01% 1847
2023
Q4 		$4.15K Buy
+266
New +$4.95K ﹤0.01% 1727

Other funds holding HELP

VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Sphera Funds Management
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Nan Fung Group Holdings
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Jump Financial's HELP Position: Q2 2026 in Review

Jump Financial increased its Helus Pharma Inc. Common Stock (HELP) stake by 8.1% in Q2 2026, buying an estimated $7.27K and bringing the position to 19,453 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

Jump Financial first reported a position in HELP in Q4 2023 and has held it in 5 quarters since. The position peaked at $328K in Q3 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Jump Financial held 19,453 shares of Helus Pharma Inc. Common Stock worth $129K as of Q2 2026.
  • Jump Financial bought 1,453 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $7.27K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1895 holding.
  • Jump Financial first reported a position in Helus Pharma Inc. Common Stock in Q4 2023 and has held it in 5 quarters since.
  • Jump Financial's Helus Pharma Inc. Common Stock position peaked at $328K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.